Form 8-K - Current report:
SEC Accession No. 0001628280-21-014889
Filing Date
2021-07-29
Accepted
2021-07-29 16:16:11
Documents
14
Period of Report
2021-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20210729.htm   iXBRL 8-K 40769
2 EX-99.1 exhibit991preliminaryresul.htm EX-99.1 23480
6 imagea.jpg GRAPHIC 21590
  Complete submission text file 0001628280-21-014889.txt   247688

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20210729.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20210729_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20210729_pre.xml EX-101.PRE 13582
7 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20210729_htm.xml XML 12573
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 211127622
SIC: 3841 Surgical & Medical Instruments & Apparatus